Patent · US Active

Anti-human cytomegalovirus antibodies

US7763261B2 · kind B2 · utility

1Cited by
4References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2008
Grant dateJul 27, 2010
Priority date
Expiry dateOct 27, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features a human antibody that specifically binds to human cytomegalovirus (HCMV), its encoding nucleic acid(s), and use of the antibody/nucleic acid(s) in treating HCMV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.